H.C. Wainwright reiterates Summit Therapeutics stock rating as Neutral

Investing.com•Wed, Sep 30, 2026, 11:56 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-summit-therapeutics-stock-rating-as-neutral-93CH-4924962)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #wainwright #reiterates #summit #therapeutics #stock #rating #neutral

More Headlines

FinanceSeeking Alpha• 9m ago

Pharming Group: Viable Contrarian Buy If Ruconest Stabilizes

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 11m ago

Private sector jobs rose by 90,000 in September, better than expected, ADP reports

Private job creation picked up in September after a brief slowdown.

FinanceCNBC• 11m ago

More Americans are tapping investments to pay for spending, analysis finds

Across all age and income groups examined in new research, the share of individuals transferring money from investment accounts to checking accounts has risen.

FinanceSeeking Alpha• 11m ago

New Home Sales Jump As Buyers Take Advantage Of Builder Incentives

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 16m ago

Boeing rises 3% after securing U.S. navy deal to develop next-generation fighter jet

The Department of War and the U. S. Navy said Tuesday that it's chosen aircraft manufacturer Boeing to develop its next generation of fighter jets.

FinanceCNBC• 19m ago

People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

The data on Novo's Wegovy pill suggests that patients may not need to take weekly injections forever, but can instead opt for more convenient treatments.